Free Trial

Cboe Global Markets (CBOE) Financials

Cboe Global Markets logo
$346.00 +2.02 (+0.59%)
Closing price 04:10 PM Eastern
Extended Trading
$345.50 -0.50 (-0.14%)
As of 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Cboe Global Markets

Annual Income Statements for Cboe Global Markets

This table shows Cboe Global Markets' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
204 185 397 422 373 467 527 234 758 761 1,095
Consolidated Net Income / (Loss)
205 186 401 425 371 468 529 235 761 765 1,100
Net Income / (Loss) Continuing Operations
205 186 401 425 371 468 529 235 761 765 1,100
Total Pre-Tax Income
324 307 334 571 501 660 756 433 1,048 1,084 1,567
Total Operating Income
320 298 372 599 537 662 806 490 1,058 1,098 1,467
Total Gross Profit
562 566 794 988 1,137 1,254 1,476 1,742 1,918 1,610 1,928
Total Revenue
664 703 2,229 2,769 2,496 3,427 3,495 3,959 3,774 4,095 4,714
Operating Revenue
644 703 2,229 2,769 2,496 3,427 3,495 3,959 3,774 4,095 4,714
Total Cost of Revenue
100 137 1,435 1,781 1,359 2,173 2,019 2,217 1,856 2,485 2,786
Operating Cost of Revenue
100 137 1,435 1,781 1,359 2,173 2,019 2,217 1,856 2,485 2,786
Total Operating Expenses
242 268 422 389 600 592 670 1,252 860 512 461
Selling, General & Admin Expense
182 194 118 130 352 364 455 556 631 226 224
Depreciation Expense
46 44 192 204 177 159 167 167 158 133 122
Other Operating Expenses / (Income)
14 17 28 25 23 24 32 49 63 70 68
Impairment Charge
- - - - - 0.00 0.00 461 - 81 47
Restructuring Charge
0.00 14 84 30 49 45 16 20 7.40 1.30 0.30
Total Other Income / (Expense), net
4.10 8.40 -38 -28 -36 -1.80 -51 -57 -10 -15 100
Interest Expense
- - - - - - 48 60 62 52 52
Interest & Investment Income
0.00 -5.70 -41 -38 -36 -38 0.60 11 52 56 142
Other Income / (Expense), net
4.10 14 3.80 10 0.10 36 -3.40 -7.50 0.60 -19 9.60
Income Tax Expense
119 121 -66 146 131 192 227 198 286 319 467
Net Income / (Loss) Attributable to Noncontrolling Interest
0.90 -0.30 2.80 1.80 -2.40 1.20 1.70 0.90 3.90 3.90 5.20
Basic Earnings per Share
$2.46 $2.27 $3.70 $3.78 $3.35 $4.28 $4.93 $2.20 $7.16 $7.24 $10.46
Weighted Average Basic Shares Outstanding
83.10M 81.40M 107.20M 111.80M 111.40M 109.10M 107M 106.30M 105.80M 105.10M 104.70M
Diluted Earnings per Share
$2.46 $2.27 $3.69 $3.76 $3.34 $4.27 $4.92 $2.19 $7.13 $7.21 $10.42
Weighted Average Diluted Shares Outstanding
83.10M 81.40M 107.50M 112.20M 111.80M 109.30M 107.20M 106.70M 106.20M 105.50M 105.10M
Weighted Average Basic & Diluted Shares Outstanding
81.80M 81.29M 112.70M 111.60M 110.44M 107.21M 106.60M 105.74M 105.58M 104.70M 104.67M
Cash Dividends to Common per Share
$0.88 $0.96 $1.04 $1.16 $1.34 $1.56 $1.80 $1.96 $2.10 $2.36 $2.70

Quarterly Income Statements for Cboe Global Markets

This table shows Cboe Global Markets' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
167 207 211 208 140 217 196 249 234 299 312
Consolidated Net Income / (Loss)
168 208 212 210 140 219 197 251 235 301 314
Net Income / (Loss) Continuing Operations
168 208 212 210 140 219 197 251 235 301 314
Total Pre-Tax Income
242 270 288 292 203 309 280 350 335 430 452
Total Operating Income
245 271 294 282 210 307 299 354 339 370 404
Total Gross Profit
467 481 499 387 398 532 178 449 459 476 544
Total Revenue
908 909 969 957 974 1,056 1,108 1,195 1,174 1,142 1,204
Operating Revenue
908 909 969 957 974 1,056 1,108 1,195 1,174 1,142 1,204
Total Cost of Revenue
441 428 470 570 576 524 929 746 714 665 660
Operating Cost of Revenue
441 428 470 570 576 524 929 746 714 665 660
Total Operating Expenses
222 209 205 104 188 225 -120 95 120 106 140
Selling, General & Admin Expense
162 155 153 53 59 174 -175 52 58 52 61
Depreciation Expense
40 39 38 37 32 32 32 30 30 31 31
Other Operating Expenses / (Income)
20 15 15 14 15 19 23 13 15 18 22
Restructuring Charge
0.70 0.80 -0.50 0.60 0.60 0.00 0.10 0.20 0.00 0.20 -0.10
Total Other Income / (Expense), net
-3.00 -1.10 -6.50 9.70 -7.10 1.60 -19 -3.70 -4.50 60 48
Interest Expense
17 15 13 13 13 13 13 13 13 13 13
Interest & Investment Income
12 14 8.30 18 19 12 7.00 5.10 10 67 60
Other Income / (Expense), net
1.60 0.50 -1.60 4.60 -13 2.00 -13 4.00 -1.80 6.10 1.30
Income Tax Expense
74 62 76 83 63 91 83 100 100 129 138
Net Income / (Loss) Attributable to Noncontrolling Interest
0.80 1.10 1.20 1.20 0.70 1.10 0.90 1.20 1.20 1.50 1.30
Basic Earnings per Share
$1.58 $1.96 $1.99 $1.97 $1.33 $2.08 $1.86 $2.38 $2.23 $2.86 $2.99
Weighted Average Basic Shares Outstanding
105.70M 105.70M 105.80M 105.60M 105.10M 104.70M 105.10M 104.70M 104.70M 104.60M 104.70M
Diluted Earnings per Share
$1.57 $1.95 $1.98 $1.96 $1.33 $2.07 $1.85 $2.37 $2.23 $2.85 $2.97
Weighted Average Diluted Shares Outstanding
106.10M 106.10M 106.20M 106.10M 105.40M 105.10M 105.50M 105.10M 105M 104.90M 105.10M
Weighted Average Basic & Diluted Shares Outstanding
105.52M 105.56M 105.58M 105.15M 104.63M 104.69M 104.70M 104.71M 104.59M 104.64M 104.67M

Annual Cash Flow Statements for Cboe Global Markets

This table details how cash moves in and out of Cboe Global Markets' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-46 -5.00 46 132 -46 828 35 -112 417 369 2,103
Net Cash From Operating Activities
245 230 374 535 633 1,459 597 651 1,076 1,101 1,753
Net Cash From Continuing Operating Activities
245 230 374 535 633 1,459 597 651 1,076 1,101 1,753
Net Income / (Loss) Continuing Operations
205 186 401 425 371 468 529 235 761 765 1,100
Consolidated Net Income / (Loss)
205 186 401 425 371 468 529 235 761 765 1,100
Depreciation Expense
46 44 192 204 177 159 167 167 158 133 122
Non-Cash Adjustments To Reconcile Net Income
12 12 27 9.10 84 72 -145 381 198 333 357
Changes in Operating Assets and Liabilities, net
-18 -12 -249 -106 -0.40 759 43 -134 -41 -131 174
Net Cash From Investing Activities
-79 -84 -1,437 -26 -16 -431 -353 -835 -55 -142 450
Net Cash From Continuing Investing Activities
-79 -84 -1,437 -26 -16 -431 -353 -835 -55 -142 450
Purchase of Property, Plant & Equipment
-39 -44 -38 -36 -35 -47 -51 -60 -45 -61 -71
Purchase of Investments
0.00 0.00 -140 -166 -109 -235 -311 -119 -147 -156 -177
Sale of Property, Plant & Equipment
- - - - - - - 0.00 0.00 4.00 0.00
Divestitures
- - - - 0.00 - 0.00 0.00 0.80 0.10 1.60
Sale and/or Maturity of Investments
0.00 0.00 155 179 98 203 160 52 136 71 255
Other Investing Activities, net
-37 -24 0.00 -1.80 30 0.50 0.60 0.00 0.30 0.10 442
Net Cash From Financing Activities
-212 -150 1,100 -372 -663 -202 -200 82 -656 -495 -372
Net Cash From Continuing Financing Activities
-212 -150 1,100 -372 -663 -202 -200 82 -656 -495 -372
Repayment of Debt
0.00 -8.20 -702 -364 -350 -230 -20 -225 -305 -6.00 0.00
Repurchase of Common Equity
-132 -61 0.00 -141 -157 -349 -81 -101 -84 -205 -67
Payment of Dividends
-73 -79 -118 -130 -150 -171 -193 -209 -224 -249 -284
Issuance of Common Equity
- - - - - 0.00 -0.40 -0.60 -17 8.60 9.20
Other Financing Activities, net
-5.90 -3.00 -24 -75 -6.00 -16 -15 -46 -27 -43 -30
Effect of Exchange Rate Changes
0.00 0.00 8.60 - - 1.60 -9.10 -10 53 -95 272
Cash Interest Paid
0.00 0.00 27 39 33 29 42 51 57 100 92
Cash Income Taxes Paid
134 142 177 213 135 192 210 271 286 362 392

Quarterly Cash Flow Statements for Cboe Global Markets

This table details how cash moves in and out of Cboe Global Markets' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents
-756 595 -335 689 1,263 -546 -1,036 904 287 213 699
Net Cash From Operating Activities
-503 737 -189 896 1,494 -579 -710 913 334 154 352
Net Cash From Continuing Operating Activities
-512 737 -189 896 1,494 -579 -710 913 334 154 352
Net Income / (Loss) Continuing Operations
168 208 212 210 140 219 197 251 235 301 314
Consolidated Net Income / (Loss)
168 208 212 210 140 219 197 251 235 301 314
Depreciation Expense
40 39 38 37 32 32 32 30 30 31 31
Non-Cash Adjustments To Reconcile Net Income
-695 517 -457 721 1,363 -830 -924 642 17 -282 -20
Changes in Operating Assets and Liabilities, net
-26 -28 17 -73 -42 0.20 -16 -10 51 104 29
Net Cash From Investing Activities
-45 26 -38 -13 -37 35 -127 -20 -117 168 419
Net Cash From Continuing Investing Activities
-45 26 -38 -13 -37 35 -127 -20 -117 168 419
Purchase of Property, Plant & Equipment
-7.80 -7.70 -17 -7.30 -18 -12 -24 -15 -20 -16 -20
Sale and/or Maturity of Investments
- 71 - 21 - 47 2.80 70 - 178 7.00
Other Investing Activities, net
2.10 - 0.30 0.10 - - - 4.60 - 4.90 432
Net Cash From Financing Activities
-208 -165 -143 -169 -178 -78 -71 -115 -104 -76 -78
Net Cash From Continuing Financing Activities
-208 -165 -143 -169 -178 -78 -71 -115 -104 -76 -78
Payment of Dividends
-53 -59 -59 -59 -58 -66 -66 -66 -66 -76 -76
Other Financing Activities, net
-5.60 -1.50 -2.30 -29 -12 -1.80 -7.40 -23 -0.70 -4.50 -1.70
Effect of Exchange Rate Changes
-0.80 -2.60 35 -25 -16 75 -129 126 174 -33 4.90
Cash Interest Paid
17 12 6.30 17 45 20 18 27 20 30 15
Cash Income Taxes Paid
120 74 83 77 102 93 91 8.00 141 92 151

Annual Balance Sheets for Cboe Global Markets

This table presents Cboe Global Markets' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
385 477 5,266 5,321 5,114 6,517 6,815 6,999 7,488 7,789 9,305
Total Current Assets
204 235 435 684 608 1,567 1,531 1,556 1,979 2,479 4,421
Cash & Equivalents
102 97 144 275 229 245 342 433 543 920 2,217
Short-Term Investments
- 0.00 47 36 71 92 37 92 58 110 36
Accounts Receivable
63 77 217 287 235 337 327 370 337 445 391
Current Deferred & Refundable Income Taxes
28 54 17 70 57 53 43 48 75 74 68
Other Current Assets
6.31 7.40 9.40 15 16 839 783 614 967 930 1,710
Plant, Property, & Equipment, net
60 4.90 4.90 4.90 0.00 0.00 2.30 2.30 0.00 0.00 0.00
Total Noncurrent Assets
120 237 4,826 4,632 4,506 4,950 5,281 5,441 5,508 5,310 4,884
Long-Term Investments
- 73 83 86 61 43 246 253 345 384 32
Goodwill
7.66 27 2,707 2,691 2,682 2,895 3,025 3,123 3,141 3,124 3,151
Intangible Assets
2.38 8.70 1,903 1,720 1,590 1,729 1,669 1,663 1,562 1,377 1,297
Other Noncurrent Operating Assets
67 129 133 135 173 283 341 402 461 425 404
Total Liabilities & Shareholders' Equity
385 477 5,266 5,321 5,114 6,517 6,815 6,999 7,488 7,789 9,305
Total Liabilities
125 146 2,146 2,071 1,758 3,168 3,210 3,534 3,503 3,510 4,167
Total Current Liabilities
74 90 334 596 282 1,313 1,169 1,477 1,383 1,395 2,362
Accounts Payable
60 82 154 199 172 250 295 420 413 360 687
Customer Deposits
- - - - 0.00 812 746 543 849 846 1,618
Current Deferred Revenue
4.02 3.10 15 8.50 4.50 10 15 12 5.90 6.40 6.90
Current Deferred & Payable Income Tax Liabilities
1.63 0.00 2.60 4.10 4.00 4.20 8.20 3.50 1.00 1.60 50
Other Current Liabilities
- 4.40 106 81 99 153 41 170 103 182 0.20
Total Noncurrent Liabilities
51 56 1,812 1,475 1,477 1,854 2,040 2,056 2,119 2,114 1,805
Long-Term Debt
- 0.00 1,238 916 868 1,135 1,299 1,437 1,439 1,441 1,443
Noncurrent Deferred Revenue
40 52 79 115 136 165 198 196 244 305 16
Noncurrent Deferred & Payable Income Tax Liabilities
5.31 0.00 488 437 400 378 373 223 218 187 185
Other Noncurrent Operating Liabilities
4.26 4.20 6.80 7.40 74 177 171 200 218 182 161
Commitments & Contingencies
0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
260 318 3,111 3,241 3,356 3,349 3,605 3,465 3,985 4,280 5,138
Total Preferred & Common Equity
260 318 3,111 3,241 3,356 3,349 3,605 3,465 3,985 4,280 5,138
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
260 318 3,111 3,241 3,356 3,349 3,605 3,465 3,985 4,280 5,138
Common Stock
125 140 2,625 2,661 2,693 2,715 1,511 1,456 1,480 1,514 1,566
Retained Earnings
604 711 993 1,288 1,513 1,810 2,146 2,171 2,525 2,816 3,544
Treasury Stock
-468 -532 -558 -720 -887 -1,250 -107 -131 -11 -1.40 -1.50
Accumulated Other Comprehensive Income / (Loss)
-0.82 -0.80 51 12 38 75 56 -31 -9.40 -48 30

Quarterly Balance Sheets for Cboe Global Markets

This table presents Cboe Global Markets' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets
7,297 7,904 7,196 7,733 8,152 9,256 8,712 8,667 9,048 9,069
Total Current Assets
1,897 2,458 1,744 2,278 2,675 3,900 3,318 3,362 3,743 3,742
Cash & Equivalents
353 436 414 403 536 615 763 1,047 1,256 1,497
Short-Term Investments
27 80 104 34 59 84 39 106 208 34
Accounts Receivable
380 393 364 359 370 373 376 493 444 437
Current Deferred & Refundable Income Taxes
40 4.50 38 60 6.80 35 47 1.40 41 34
Other Current Assets
1,097 1,544 825 1,421 1,703 2,794 2,092 1,714 1,794 1,740
Plant, Property, & Equipment, net
0.00 2.30 2.30 0.00 106 0.00 0.00 119 0.00 0.00
Total Noncurrent Assets
5,400 5,443 5,449 5,455 5,371 5,356 5,394 5,186 5,305 5,327
Long-Term Investments
254 270 294 343 362 360 358 383 380 430
Goodwill
3,114 3,128 3,138 3,125 3,134 3,133 3,151 3,132 3,156 3,147
Intangible Assets
1,666 1,637 1,614 1,571 1,527 1,425 1,425 1,368 1,356 1,330
Other Noncurrent Operating Assets
367 409 402 416 349 439 460 303 414 419
Total Liabilities & Shareholders' Equity
7,297 7,904 7,196 7,733 8,152 9,256 8,712 8,667 9,048 9,069
Total Liabilities
4,004 4,365 3,532 3,944 4,128 5,234 4,503 4,215 4,383 4,184
Total Current Liabilities
1,545 2,304 1,468 1,850 2,007 3,159 2,390 2,098 2,387 2,179
Accounts Payable
401 368 391 376 305 291 305 299 467 518
Customer Deposits
1,029 1,453 719 1,325 - 2,729 - - 1,670 1,641
Current Deferred Revenue
16 22 14 9.10 13 9.90 6.00 13 11 6.80
Current Deferred & Payable Income Tax Liabilities
0.00 19 0.00 0.00 0.00 0.00 0.00 7.80 0.00 13
Other Current Liabilities
62 117 165 52 1,681 128 2,079 1,778 238 0.20
Total Noncurrent Liabilities
2,458 2,061 2,063 2,095 2,121 2,075 2,113 2,117 1,997 2,005
Long-Term Debt
1,860 1,438 1,438 1,439 1,440 1,440 1,441 1,442 1,442 1,442
Noncurrent Deferred Revenue
185 211 224 234 257 271 287 324 213 235
Noncurrent Deferred & Payable Income Tax Liabilities
239 211 206 213 214 195 197 183 175 162
Other Noncurrent Operating Liabilities
175 202 195 209 210 169 189 169 167 165
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,294 3,539 3,664 3,788 4,024 4,022 4,208 4,452 4,665 4,885
Total Preferred & Common Equity
3,294 3,539 3,664 3,788 4,024 4,022 4,208 4,452 4,665 4,885
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,294 3,539 3,664 3,788 4,024 4,022 4,208 4,452 4,665 4,885
Common Stock
1,534 1,473 1,483 1,507 1,496 1,507 1,523 1,531 1,544 1,561
Retained Earnings
2,065 2,291 2,406 2,556 2,676 2,758 2,911 3,000 3,169 3,394
Treasury Stock
-201 -214 -222 -223 -125 -217 -243 -54 -91 -95
Accumulated Other Comprehensive Income / (Loss)
-104 -12 -2.40 -51 -23 -26 18 -25 42 25

Annual Metrics And Ratios for Cboe Global Markets

This table displays calculated financial ratios and metrics derived from Cboe Global Markets' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.55% 5.92% 434.08% 48.42% -19.70% 37.30% 1.98% 13.27% -4.67% 8.51% 15.13%
EBITDA Growth
4.66% 116.64% 273.90% 237.31% -36.70% -60.04% 13.23% -33.00% 87.18% -0.39% 31.94%
EBIT Growth
3.25% 280.79% -119.55% 1,159.84% -35.49% -56.70% 14.97% -39.93% 119.56% 1.94% 36.86%
NOPAT Growth
5.29% -32.30% 1,180.04% 0.00% -55.48% 18.17% 20.10% -52.86% 189.29% 0.82% 32.89%
Net Income Growth
8.06% -18.83% 347.17% 18.42% -38.38% 26.27% 12.99% -55.58% 224.00% 0.46% 43.81%
EPS Growth
11.31% -15.45% 125.11% 5.69% -33.51% 27.84% 15.22% -55.49% 225.57% 1.12% 44.52%
Operating Cash Flow Growth
-6.61% -19.20% 189.20% 128.45% 55.04% 130.53% -59.09% 9.10% 65.20% 2.32% 59.24%
Free Cash Flow Firm Growth
3.14% -225.17% -31,812.96% 0.00% 0.00% -84.71% -89.82% -62.01% 372.46% 30.88% 8.48%
Invested Capital Growth
13.86% 113.52% 3,504.30% -150.79% -205.11% -45.81% 3.72% 2.55% 0.81% -4.09% -0.23%
Revenue Q/Q Growth
2.90% -17.39% 457.97% 9.61% -7.13% 33.88% 0.64% 3.62% -0.95% 3.51% 2.09%
EBITDA Q/Q Growth
-1.55% 254.12% 314.16% -12.34% -74.69% 1.56% 9.62% 4.32% 3.52% -1.05% 7.85%
EBIT Q/Q Growth
-2.11% 147.57% -113.48% 39.50% -31.22% 2.27% 11.68% 5.24% 4.76% -0.63% 8.80%
NOPAT Q/Q Growth
-1.57% -56.41% 464.05% 0.00% -138.04% 1.52% 16.27% -2.37% 6.45% -0.87% 7.32%
Net Income Q/Q Growth
0.51% -28.76% 494.25% -65.47% -37.64% 0.45% 17.45% -2.57% 7.38% -1.99% 11.90%
EPS Q/Q Growth
1.23% -28.20% 505.46% -71.20% -36.32% 0.95% 17.70% -2.23% 7.22% -1.77% 12.04%
Operating Cash Flow Q/Q Growth
-46.30% 2,114.66% 185.86% 30.32% 5.36% 2.22% -61.62% 513.67% -4.05% -32.15% 153.96%
Free Cash Flow Firm Q/Q Growth
-55.42% 0.00% -547.14% 0.00% 20,597.57% -51.88% 334.08% 29.52% -1.44% 15.64% -3.85%
Invested Capital Q/Q Growth
23.12% -90.37% 583.98% -3.85% -104.90% 4.35% -1.38% -2.25% -1.00% -4.05% -1.60%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
84.62% 241.67% 124.96% 123.59% 136.64% 36.60% 42.24% 44.00% 50.83% 39.32% 40.90%
EBITDA Margin
55.78% 114.09% 112.05% 58.94% 86.07% 25.05% 27.82% 16.45% 32.31% 29.66% 33.92%
Operating Margin
48.19% 127.24% 50.05% 43.30% 64.56% 19.32% 23.06% 12.37% 28.04% 26.83% 31.12%
EBIT Margin
48.81% 133.25% 50.56% 66.03% 64.58% 20.37% 22.96% 12.18% 28.05% 26.35% 31.32%
Profit (Net Income) Margin
30.88% 79.23% 53.91% 30.71% 44.57% 13.66% 15.14% 5.94% 20.18% 18.68% 23.33%
Tax Burden Percent
63.27% 181.70% 359.39% 0.00% 147.91% 70.90% 69.96% 54.29% 72.68% 70.58% 70.22%
Interest Burden Percent
100.00% 294.52% 267.02% 0.00% 279.96% 94.61% 94.22% 89.79% 98.97% 100.44% 106.09%
Effective Tax Rate
36.73% 118.30% -59.39% 0.00% 78.14% 29.10% 30.04% 45.71% 27.32% 29.42% 29.78%
Return on Invested Capital (ROIC)
185.32% 261.19% 19.97% 7.22% 4.94% 7.88% 13.22% 6.04% 17.19% 17.63% 23.95%
ROIC Less NNEP Spread (ROIC-NNEP)
183.54% 384.46% 28.81% 11.51% 9.48% 7.74% 8.80% 2.48% 16.19% 13.75% 6.81%
Return on Net Nonoperating Assets (RNNOA)
-104.89% -167.02% 6.62% 5.18% 4.27% 2.14% 2.00% 0.61% 3.25% 0.88% -0.59%
Return on Equity (ROE)
80.44% 0.00% 72.67% 19.62% 19.09% 10.02% 15.21% 6.65% 20.44% 18.51% 23.36%
Cash Return on Invested Capital (CROIC)
172.36% -51.40% -950.83% 0.00% 182.35% 67.30% 9.57% 3.53% 16.38% 21.80% 24.18%
Operating Return on Assets (OROA)
84.30% 217.51% 40.44% 23.03% 40.79% 12.00% 12.04% 6.98% 14.61% 14.13% 17.28%
Return on Assets (ROA)
53.34% 129.33% 44.38% 16.07% 28.15% 8.05% 7.94% 3.40% 10.51% 10.01% 12.87%
Return on Common Equity (ROCE)
80.44% 184.77% 63.51% 29.35% 22.48% 10.02% 15.21% 6.65% 20.44% 18.51% 23.36%
Return on Equity Simple (ROE_SIMPLE)
78.95% 175.24% 38.64% 26.24% 22.10% 13.98% 14.67% 6.78% 19.11% 17.87% 0.00%
Net Operating Profit after Tax (NOPAT)
202 181 891 892 397 469 564 266 769 775 1,030
NOPAT Margin
30.49% 77.06% 39.97% 32.23% 47.75% 13.70% 16.13% 6.71% 20.38% 18.93% 21.85%
Net Nonoperating Expense Percent (NNEP)
1.78% 9.74% 39.60% 2.93% 5.34% 0.14% 4.42% 3.56% 1.00% 3.88% 17.14%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 5.08% 14.14% 13.55% 15.65%
Cost of Revenue to Revenue
15.03% 90.53% 193.11% 192.94% 179.30% 63.40% 57.76% 56.00% 49.17% 60.68% 59.10%
SG&A Expenses to Revenue
27.34% 82.56% 15.91% 14.11% 28.18% 10.63% 13.03% 14.04% 16.73% 5.52% 4.74%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
36.43% 114.44% 74.90% 42.12% 48.05% 17.28% 19.18% 31.63% 22.79% 12.49% 9.78%
Earnings before Interest and Taxes (EBIT)
324 625 376 1,828 1,612 698 803 482 1,059 1,079 1,477
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
370 802 1,535 2,448 2,148 859 972 651 1,219 1,214 1,599
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
18.33 34.84 8.24 9.62 11.58 2.85 3.72 3.74 4.67 4.78 5.11
Price to Tangible Book Value (P/TBV)
19.07 39.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 38.03
Price to Revenue (P/Rev)
7.17 23.76 11.50 7.56 15.57 2.79 3.83 3.28 4.94 5.00 5.57
Price to Earnings (P/E)
23.32 90.36 96.58 75.23 103.25 20.44 25.42 55.38 24.59 26.88 23.99
Dividend Yield
1.52% 4.29% 2.72% 4.05% 3.76% 1.77% 1.43% 1.60% 1.19% 1.21% 1.08%
Earnings Yield
4.29% 10.15% 9.47% 12.38% 8.86% 4.89% 3.93% 1.81% 4.07% 3.72% 4.17%
Enterprise Value to Invested Capital (EV/IC)
40.07 101.28 9.99 5.48 10.34 2.48 3.26 3.13 4.26 4.76 5.92
Enterprise Value to Revenue (EV/Rev)
7.02 23.03 18.57 12.37 16.09 3.03 4.05 3.53 5.07 5.00 5.39
Enterprise Value to EBITDA (EV/EBITDA)
12.58 45.70 48.62 41.39 55.87 12.10 14.55 21.42 15.69 16.87 15.90
Enterprise Value to EBIT (EV/EBIT)
14.38 51.99 110.07 36.66 74.46 14.88 17.62 28.94 18.07 18.98 17.22
Enterprise Value to NOPAT (EV/NOPAT)
23.02 59.33 93.15 75.40 101.07 22.12 25.08 52.50 24.88 26.42 24.68
Enterprise Value to Operating Cash Flow (EV/OCF)
19.00 71.18 110.45 63.00 63.46 7.12 23.69 21.43 17.79 18.61 14.51
Enterprise Value to Free Cash Flow (EV/FCFF)
24.75 0.00 0.00 0.00 8.22 2.59 34.64 89.98 26.11 21.36 24.44
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.01 0.00 1.24 0.00 0.00 0.36 0.38 0.51 0.36 0.34 0.28
Long-Term Debt to Equity
0.00 0.00 0.79 0.00 0.00 0.34 0.36 0.41 0.36 0.34 0.28
Financial Leverage
-0.57 -1.50 0.39 1.38 1.66 0.28 0.23 0.24 0.20 0.06 -0.09
Leverage Ratio
1.51 4.38 5.02 5.01 4.80 1.73 1.92 1.95 1.94 1.85 1.82
Compound Leverage Factor
1.51 4.31 4.49 0.00 4.48 1.64 1.81 1.75 1.92 1.86 1.93
Debt to Total Capital
0.76% 0.00% 87.97% 0.00% 0.00% 26.69% 27.44% 33.76% 26.69% 25.19% 21.92%
Short-Term Debt to Total Capital
0.76% 0.00% 2.56% 20.38% 0.00% 1.84% 1.28% 6.29% 0.22% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 56.08% 61.45% 0.00% 24.85% 26.15% 27.47% 26.48% 25.19% 21.92%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.64% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
99.24% 288.56% 211.39% 0.00% 0.00% 73.31% 72.56% 66.24% 73.31% 74.81% 78.08%
Debt to EBITDA
0.01 0.00 6.80 4.48 3.64 1.42 1.40 2.71 1.19 1.19 0.90
Net Debt to EBITDA
-0.27 0.00 5.36 3.02 2.13 0.98 0.76 1.52 0.41 0.02 -0.53
Long-Term Debt to EBITDA
0.00 0.00 6.50 3.37 3.63 1.32 1.34 2.21 1.18 1.19 0.90
Debt to NOPAT
0.01 0.00 8.72 8.20 6.57 2.60 2.42 6.65 1.89 1.86 1.40
Net Debt to NOPAT
-0.50 0.00 6.88 5.53 3.84 1.79 1.31 3.72 0.66 0.03 -0.82
Long-Term Debt to NOPAT
0.00 0.00 8.34 6.16 6.55 2.42 2.30 5.41 1.87 1.86 1.40
Altman Z-Score
29.93 0.00 13.72 8.51 17.11 3.12 3.91 3.44 4.73 5.15 5.61
Noncontrolling Interest Sharing Ratio
0.00% 6.41% 1.91% 0.89% 0.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.76 0.00 6.51 0.00 0.00 1.19 1.31 1.05 1.43 1.78 1.87
Quick Ratio
2.23 0.00 6.11 0.00 0.00 0.51 0.60 0.61 0.68 1.06 1.12
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
188 -24 -20,551 0.00 26,225 4,010 408 155 733 959 1,040
Operating Cash Flow to CapEx
624.17% 1,551.35% 2,995.20% 4,419.01% 5,408.55% 3,077.64% 1,170.20% 1,088.80% 2,390.22% 1,934.27% 2,468.45%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 8.51 2.58 11.74 18.62 19.89
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 12.43 10.85 17.24 21.37 33.51
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 11.37 9.86 16.52 20.27 32.15
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.73 4.90 2.33 1.05 1.90 0.59 0.52 0.57 0.52 0.54 0.55
Accounts Receivable Turnover
10.98 10.10 15.16 21.95 19.13 11.98 10.52 11.36 10.67 10.47 11.28
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
10.44 64.64 454.92 565.06 0.00 0.00 0.00 1,721.09 0.00 0.00 0.00
Accounts Payable Turnover
1.68 8.93 12.15 20.22 7.34 10.30 7.40 6.20 4.46 6.43 5.32
Days Sales Outstanding (DSO)
33.25 108.42 72.21 99.78 114.50 30.46 34.68 32.12 34.20 34.85 32.36
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
217.01 570.75 90.12 77.54 149.20 35.44 49.31 58.91 81.92 56.74 68.56
Cash Conversion Cycle (CCC)
-183.76 -289.97 -17.91 3.31 -16.78 -4.98 -14.62 -26.79 -47.72 -21.89 -36.20
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
116 321 8,282 12,218 7,728 4,188 4,343 4,454 4,490 4,306 4,296
Invested Capital Turnover
6.08 10.26 3.00 0.90 1.03 0.58 0.82 0.90 0.84 0.93 1.10
Increase / (Decrease) in Invested Capital
14 409 23,884 11,808 -13,466 -3,540 156 111 36 -184 -10
Enterprise Value (EV)
4,660 16,235 27,592 22,343 40,379 10,384 14,140 13,954 19,130 20,482 25,424
Market Capitalization
4,760 11,075 25,583 10,129 38,854 9,546 13,401 12,965 18,625 20,456 26,266
Book Value per Share
$3.15 $7.82 $85.29 $86.66 $30.27 $31.00 $33.80 $32.67 $37.75 $40.88 $49.10
Tangible Book Value per Share
$3.03 $3.48 ($39.65) ($31.30) ($24.73) ($11.80) ($10.21) ($12.45) ($6.79) ($2.12) $6.60
Total Capital
262 331 13,244 13,409 12,676 4,568 4,968 5,231 5,436 5,721 6,581
Total Debt
2.00 0.00 3,884 3,658 2,609 1,219 1,363 1,766 1,451 1,441 1,443
Total Long-Term Debt
0.00 0.00 3,714 2,747 2,603 1,135 1,299 1,437 1,439 1,441 1,443
Net Debt
-100 -170 2,042 2,467 1,525 839 738 989 505 27 -842
Capital Expenditures (CapEx)
39 89 75 254 105 47 51 60 45 57 71
Debt-free, Cash-free Net Working Capital (DFCFNWC)
30 96 177 242 84 -0.40 47 -117 7.00 53 -194
Debt-free Net Working Capital (DFNWC)
132 290 907 1,175 985 337 426 408 608 1,084 2,059
Net Working Capital (NWC)
130 290 1,172 263 978 254 362 79 596 1,084 2,059
Net Nonoperating Expense (NNE)
-2.59 -5.09 90 0.00 26 1.28 35 31 7.49 10 -70
Net Nonoperating Obligations (NNO)
-143 -340 2,042 2,467 1,017 839 738 989 505 27 -842
Total Depreciation and Amortization (D&A)
46 178 783 1,446 536 161 170 169 161 135 122
Debt-free, Cash-free Net Working Capital to Revenue
4.50% 20.44% 7.94% 5.83% 3.35% -0.01% 1.34% -2.95% 0.19% 1.30% -4.10%
Debt-free Net Working Capital to Revenue
19.90% 61.95% 60.17% 42.42% 39.45% 9.85% 12.18% 10.30% 16.10% 26.47% 43.68%
Net Working Capital to Revenue
19.60% 61.95% 52.55% 6.34% 39.18% 7.40% 10.36% 1.99% 15.79% 26.47% 43.68%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.46 $2.27 $3.70 $3.78 $6.70 $4.28 $4.93 $2.20 $7.16 $7.24 $10.46
Adjusted Weighted Average Basic Shares Outstanding
83.08M 81.43M 107.20M 111.80M 222.80M 109.10M 107M 106.30M 105.80M 105.10M 104.70M
Adjusted Diluted Earnings per Share
$2.46 $2.27 $3.69 $3.76 $6.68 $4.27 $4.92 $2.19 $7.13 $7.21 $10.42
Adjusted Weighted Average Diluted Shares Outstanding
83.08M 81.43M 107.50M 112.20M 223.60M 109.30M 107.20M 106.70M 106.20M 105.50M 105.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
81.80M 81.29M 112.70M 111.60M 220.87M 107.21M 106.60M 105.74M 105.58M 104.70M 104.67M
Normalized Net Operating Profit after Tax (NOPAT)
202 378 639 937 433 502 575 527 774 833 1,063
Normalized NOPAT Margin
30.49% 80.58% 28.66% 50.76% 52.06% 14.63% 16.45% 13.31% 20.52% 20.35% 22.55%
Pre Tax Income Margin
48.81% 130.82% 45.00% 41.26% 60.26% 19.27% 21.64% 10.94% 27.76% 26.47% 33.23%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 16.72 8.04 16.96 20.95 28.24
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 11.75 4.43 12.32 15.05 19.70
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 15.66 7.04 16.24 19.85 26.88
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 10.68 3.43 11.60 13.95 18.34
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
35.80% 295.91% 88.44% 61.29% 121.36% 36.44% 36.54% 89.11% 29.35% 32.61% 25.85%
Augmented Payout Ratio
100.29% 523.96% 206.37% 127.56% 248.30% 111.00% 51.91% 132.04% 40.37% 59.38% 31.91%

Quarterly Metrics And Ratios for Cboe Global Markets

This table displays calculated financial ratios and metrics derived from Cboe Global Markets' official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-7.91% -8.53% -3.58% -3.14% 7.29% 16.16% 14.34% 24.84% 20.48% 8.15% 8.70%
EBITDA Growth
242.40% 8.81% 14.29% 12.00% -20.01% 9.87% -3.90% 19.67% 60.33% 19.34% 37.36%
EBIT Growth
201.73% 11.22% 19.69% 15.73% -20.05% 13.88% -2.33% 24.70% 71.22% 21.65% 41.84%
NOPAT Growth
202.23% 34.60% 27.78% 16.95% -14.46% 3.98% -3.27% 25.03% 63.97% 19.14% 33.64%
Net Income Growth
190.95% 38.62% 32.75% 20.82% -16.33% 4.95% -7.31% 19.62% 67.45% 37.67% 59.54%
EPS Growth
190.23% 38.30% 32.00% 20.25% -15.29% 6.15% -6.57% 20.92% 67.67% 37.68% 60.54%
Operating Cash Flow Growth
20.70% 335.26% -31.62% -13.12% 396.94% -178.50% -275.87% 1.93% -77.66% 126.60% 149.56%
Free Cash Flow Firm Growth
146.49% 8,072.92% 206.32% 337.83% -25.37% 14.96% 117.84% 103.84% 81.68% 44.00% -26.19%
Invested Capital Growth
-2.42% -0.46% 0.81% 0.01% -1.43% -1.04% -4.09% -3.51% -3.23% -2.72% -0.23%
Revenue Q/Q Growth
-8.14% 0.11% 6.59% -1.19% 1.76% 8.39% 4.92% 7.89% -1.80% -2.71% 5.46%
EBITDA Q/Q Growth
-1.14% 8.47% 6.43% 1.28% -29.39% 49.00% -6.90% 22.19% -5.40% 10.90% 6.99%
EBIT Q/Q Growth
-0.65% 10.27% 7.62% 1.74% -31.36% 57.06% -7.69% 25.32% -5.76% 11.59% 7.62%
NOPAT Q/Q Growth
-1.91% 23.05% 3.71% -6.57% -28.26% 49.59% -3.52% 20.76% -5.92% 8.69% 8.22%
Net Income Q/Q Growth
-3.23% 24.08% 1.83% -1.18% -32.98% 55.63% -10.07% 27.53% -6.19% 27.95% 4.22%
EPS Q/Q Growth
-3.68% 24.20% 1.54% -1.01% -32.14% 55.64% -10.63% 28.11% -5.91% 27.80% 4.21%
Operating Cash Flow Q/Q Growth
-148.81% 246.47% -125.65% 573.86% 66.80% -138.72% -22.80% 228.51% -63.45% -53.88% 128.78%
Free Cash Flow Firm Q/Q Growth
430.45% -17.97% -21.53% 11.82% 3.70% 26.34% 48.70% 4.64% -7.58% 0.14% -23.79%
Invested Capital Q/Q Growth
-1.00% 1.47% -1.00% 0.57% -2.43% 1.87% -4.05% 1.18% -2.15% 2.41% -1.60%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
51.45% 52.87% 51.51% 52.46% 40.83% 50.39% 16.09% 37.57% 39.15% 41.72% 45.15%
EBITDA Margin
31.59% 34.23% 34.18% 33.94% 23.55% 32.38% 28.73% 32.54% 31.34% 35.73% 36.25%
Operating Margin
26.97% 29.84% 30.35% 29.50% 21.57% 29.12% 26.95% 29.62% 28.90% 32.43% 33.54%
EBIT Margin
27.14% 29.90% 30.18% 29.98% 20.23% 29.31% 25.79% 29.95% 28.74% 32.97% 33.65%
Profit (Net Income) Margin
18.48% 22.91% 21.89% 21.89% 14.41% 20.70% 17.74% 20.97% 20.03% 26.35% 26.04%
Tax Burden Percent
69.40% 77.08% 73.74% 71.72% 69.16% 70.71% 70.25% 71.56% 70.26% 69.94% 69.40%
Interest Burden Percent
98.13% 99.41% 98.32% 101.78% 103.05% 99.87% 97.93% 97.85% 99.20% 114.27% 111.50%
Effective Tax Rate
30.60% 22.92% 26.26% 28.28% 30.84% 29.29% 29.75% 28.44% 29.74% 30.06% 30.60%
Return on Invested Capital (ROIC)
16.10% 19.28% 18.88% 17.54% 12.80% 18.05% 17.63% 20.70% 21.23% 23.66% 25.51%
ROIC Less NNEP Spread (ROIC-NNEP)
15.91% 19.19% 18.24% 18.49% 11.98% 18.27% 12.66% 19.36% 57.57% -11.37% 17.36%
Return on Net Nonoperating Assets (RNNOA)
4.88% 5.45% 3.66% 3.59% 1.85% 2.35% 0.81% 0.91% -0.12% 0.30% -1.50%
Return on Equity (ROE)
20.98% 24.72% 22.54% 21.13% 14.66% 20.40% 18.44% 21.60% 21.11% 23.96% 24.01%
Cash Return on Invested Capital (CROIC)
17.21% 16.35% 16.38% 17.66% 18.88% 18.38% 21.80% 22.18% 24.47% 24.44% 24.18%
Operating Return on Assets (OROA)
14.41% 15.16% 15.73% 13.98% 9.37% 14.10% 13.82% 15.43% 14.23% 17.12% 18.56%
Return on Assets (ROA)
9.81% 11.61% 11.40% 10.20% 6.67% 9.96% 9.51% 10.80% 9.92% 13.69% 14.36%
Return on Common Equity (ROCE)
20.98% 24.72% 22.54% 21.13% 14.66% 20.40% 18.44% 21.60% 21.11% 23.96% 24.01%
Return on Equity Simple (ROE_SIMPLE)
17.77% 18.72% 0.00% 19.82% 19.15% 18.54% 0.00% 18.10% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
170 209 217 203 145 217 210 253 238 259 280
NOPAT Margin
18.71% 23.00% 22.38% 21.16% 14.92% 20.59% 18.93% 21.19% 20.30% 22.68% 23.28%
Net Nonoperating Expense Percent (NNEP)
0.20% 0.08% 0.64% -0.95% 0.83% -0.22% 4.97% 1.34% -36.34% 35.03% 8.15%
Return On Investment Capital (ROIC_SIMPLE)
- - 3.99% - - - 3.67% 4.30% 3.90% 4.09% 4.26%
Cost of Revenue to Revenue
48.55% 47.13% 48.49% 47.54% 59.17% 49.61% 83.91% 62.43% 60.85% 58.28% 54.85%
SG&A Expenses to Revenue
17.86% 17.01% 15.77% 17.53% 6.04% 16.51% -15.80% 4.35% 4.95% 4.55% 5.10%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
24.49% 23.03% 21.16% 22.95% 19.26% 21.28% -10.86% 7.96% 10.25% 9.28% 11.61%
Earnings before Interest and Taxes (EBIT)
246 272 292 287 197 309 286 358 337 376 405
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
287 311 331 325 229 342 318 389 368 408 436
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.93 4.30 4.67 4.80 4.45 5.09 4.78 5.32 5.23 5.25 5.11
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 159.61 62.92 38.03
Price to Revenue (P/Rev)
3.69 4.27 4.94 5.17 4.70 5.42 5.00 5.47 5.39 5.55 5.57
Price to Earnings (P/E)
22.17 23.05 24.59 24.37 23.35 27.62 26.88 29.54 27.25 26.22 23.99
Dividend Yield
1.47% 1.33% 1.19% 1.17% 1.29% 1.11% 1.21% 1.08% 1.08% 1.06% 1.08%
Earnings Yield
4.51% 4.34% 4.07% 4.10% 4.28% 3.62% 3.72% 3.39% 3.67% 3.81% 4.17%
Enterprise Value to Invested Capital (EV/IC)
3.40 3.76 4.26 4.39 4.15 4.84 4.76 5.42 5.63 5.76 5.92
Enterprise Value to Revenue (EV/Rev)
3.90 4.47 5.07 5.30 4.80 5.49 5.00 5.45 5.30 5.44 5.39
Enterprise Value to EBITDA (EV/EBITDA)
13.18 14.46 15.69 15.81 15.27 17.70 16.87 18.46 16.96 16.95 15.90
Enterprise Value to EBIT (EV/EBIT)
15.45 16.86 18.07 18.06 17.43 20.00 18.98 20.52 18.62 18.52 17.22
Enterprise Value to NOPAT (EV/NOPAT)
22.73 23.58 24.88 24.84 23.61 27.77 26.42 28.58 26.15 26.18 24.68
Enterprise Value to Operating Cash Flow (EV/OCF)
27.45 15.19 17.79 21.08 6.22 13.39 18.61 21.11 0.00 36.42 14.51
Enterprise Value to Free Cash Flow (EV/FCFF)
19.50 22.91 26.11 24.86 21.80 26.19 21.36 23.98 22.64 23.23 24.44
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.44 0.40 0.36 0.36 0.36 0.34 0.34 0.32 0.31 0.30 0.28
Long-Term Debt to Equity
0.39 0.38 0.36 0.36 0.36 0.34 0.34 0.32 0.31 0.30 0.28
Financial Leverage
0.31 0.28 0.20 0.19 0.15 0.13 0.06 0.05 0.00 -0.03 -0.09
Leverage Ratio
2.12 2.12 1.94 2.12 2.14 2.06 1.85 1.98 2.11 1.96 1.82
Compound Leverage Factor
2.08 2.11 1.91 2.16 2.21 2.05 1.81 1.94 2.09 2.23 2.02
Debt to Total Capital
30.62% 28.73% 26.69% 26.47% 26.39% 25.50% 25.19% 24.46% 23.61% 22.80% 21.92%
Short-Term Debt to Total Capital
3.39% 1.66% 0.22% 0.16% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
27.23% 27.07% 26.48% 26.31% 26.36% 25.50% 25.19% 24.46% 23.61% 22.80% 21.92%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
69.38% 71.27% 73.31% 73.53% 73.61% 74.50% 74.81% 75.54% 76.39% 77.20% 78.08%
Debt to EBITDA
1.40 1.30 1.19 1.16 1.21 1.17 1.19 1.13 1.02 0.97 0.90
Net Debt to EBITDA
0.70 0.63 0.41 0.39 0.32 0.23 0.02 -0.07 -0.28 -0.35 -0.53
Long-Term Debt to EBITDA
1.25 1.22 1.18 1.15 1.20 1.17 1.19 1.13 1.02 0.97 0.90
Debt to NOPAT
2.42 2.11 1.89 1.81 1.86 1.84 1.86 1.75 1.57 1.50 1.40
Net Debt to NOPAT
1.21 1.03 0.66 0.62 0.50 0.36 0.03 -0.11 -0.44 -0.54 -0.82
Long-Term Debt to NOPAT
2.15 1.99 1.87 1.80 1.86 1.84 1.86 1.75 1.57 1.50 1.40
Altman Z-Score
3.61 3.62 4.39 3.94 3.05 4.02 4.82 4.67 4.64 5.06 5.23
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.19 1.23 1.43 1.33 1.23 1.39 1.78 1.60 1.57 1.72 1.87
Quick Ratio
0.60 0.43 0.68 0.48 0.34 0.49 1.06 0.78 0.80 0.90 1.12
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
281 230 181 202 209 265 393 412 380 381 290
Operating Cash Flow to CapEx
-6,450.00% 9,570.13% -1,105.26% 12,268.49% 8,392.70% -4,820.83% -3,465.37% 6,210.20% 1,643.84% 961.88% 1,760.50%
Free Cash Flow to Firm to Interest Expense
16.80 14.94 13.68 15.53 16.36 20.67 30.50 32.16 29.49 28.64 21.83
Operating Cash Flow to Interest Expense
-30.13 47.85 -14.32 68.89 116.71 -45.20 -55.07 71.32 25.87 11.57 26.47
Operating Cash Flow Less CapEx to Interest Expense
-30.59 47.35 -15.61 68.33 115.32 -46.13 -56.66 70.17 24.29 10.37 24.97
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.53 0.51 0.52 0.47 0.46 0.48 0.54 0.52 0.50 0.52 0.55
Accounts Receivable Turnover
10.32 10.31 10.67 9.80 10.35 10.76 10.47 10.04 11.09 11.35 11.28
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 69.11 0.00 0.00 0.00 38.49 0.00 0.00 0.00
Accounts Payable Turnover
6.07 5.65 4.46 6.60 6.90 7.20 6.43 8.81 7.38 7.15 5.32
Days Sales Outstanding (DSO)
35.38 35.42 34.20 37.24 35.28 33.92 34.85 36.36 32.90 32.15 32.36
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
60.15 64.61 81.92 55.33 52.87 50.68 56.74 41.41 49.46 51.06 68.56
Cash Conversion Cycle (CCC)
-24.77 -29.19 -47.72 -18.09 -17.59 -16.75 -21.89 -5.05 -16.55 -18.91 -36.20
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
4,470 4,535 4,490 4,516 4,406 4,488 4,306 4,357 4,264 4,366 4,296
Invested Capital Turnover
0.86 0.84 0.84 0.83 0.86 0.88 0.93 0.98 1.05 1.04 1.10
Increase / (Decrease) in Invested Capital
-111 -21 36 0.60 -64 -47 -184 -158 -142 -122 -10
Enterprise Value (EV)
15,192 17,032 19,130 19,824 18,267 21,716 20,482 23,598 24,019 25,132 25,424
Market Capitalization
14,387 16,285 18,625 19,333 17,883 21,436 20,456 23,693 24,420 25,651 26,266
Book Value per Share
$34.71 $35.90 $37.75 $38.11 $38.25 $40.22 $40.88 $42.52 $44.55 $46.71 $49.10
Tangible Book Value per Share
($10.31) ($8.60) ($6.79) ($6.03) ($5.10) ($3.51) ($2.12) ($0.46) $1.46 $3.90 $6.60
Total Capital
5,281 5,315 5,436 5,473 5,464 5,649 5,721 5,894 6,107 6,327 6,581
Total Debt
1,617 1,527 1,451 1,448 1,442 1,441 1,441 1,442 1,442 1,442 1,443
Total Long-Term Debt
1,438 1,439 1,439 1,440 1,440 1,441 1,441 1,442 1,442 1,442 1,443
Net Debt
806 747 505 492 384 280 27 -95 -402 -519 -842
Capital Expenditures (CapEx)
7.80 7.70 17 7.30 18 12 21 15 20 16 20
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-62 79 7.00 82 44 126 53 111 -108 32 -194
Debt-free Net Working Capital (DFNWC)
455 517 608 677 742 928 1,084 1,264 1,356 1,563 2,059
Net Working Capital (NWC)
276 428 596 668 741 928 1,084 1,264 1,356 1,563 2,059
Net Nonoperating Expense (NNE)
2.08 0.85 4.79 -6.96 4.91 -1.13 13 2.65 3.16 -42 -33
Net Nonoperating Obligations (NNO)
806 747 505 492 384 280 27 -95 -402 -519 -842
Total Depreciation and Amortization (D&A)
40 39 39 38 32 32 33 31 31 32 31
Debt-free, Cash-free Net Working Capital to Revenue
-1.60% 2.08% 0.19% 2.19% 1.16% 3.18% 1.30% 2.56% -2.37% 0.70% -4.10%
Debt-free Net Working Capital to Revenue
11.68% 13.56% 16.10% 18.09% 19.49% 23.47% 26.47% 29.18% 29.93% 33.85% 43.68%
Net Working Capital to Revenue
7.09% 11.25% 15.79% 17.85% 19.45% 23.47% 26.47% 29.18% 29.93% 33.85% 43.68%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.58 $1.96 $1.99 $1.97 $1.33 $2.08 $1.86 $2.38 $2.23 $2.86 $2.99
Adjusted Weighted Average Basic Shares Outstanding
105.70M 105.70M 105.80M 105.60M 105.10M 104.70M 105.10M 104.70M 104.70M 104.60M 104.70M
Adjusted Diluted Earnings per Share
$1.57 $1.95 $1.98 $1.96 $1.33 $2.07 $1.85 $2.37 $2.23 $2.85 $2.97
Adjusted Weighted Average Diluted Shares Outstanding
106.10M 106.10M 106.20M 106.10M 105.40M 105.10M 105.50M 105.10M 105M 104.90M 105.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
105.52M 105.56M 105.58M 105.15M 104.63M 104.69M 104.70M 104.71M 104.59M 104.64M 104.67M
Normalized Net Operating Profit after Tax (NOPAT)
170 210 216 203 202 217 210 253 250 262 280
Normalized NOPAT Margin
18.77% 23.07% 22.34% 21.20% 20.71% 20.59% 18.94% 21.20% 21.33% 22.97% 23.27%
Pre Tax Income Margin
26.64% 29.72% 29.68% 30.52% 20.84% 29.27% 25.25% 29.31% 28.51% 37.67% 37.52%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
14.75 17.64 22.15 22.08 15.39 24.17 22.14 27.96 26.15 28.30 30.46
NOPAT to Interest Expense
10.17 13.57 16.42 15.58 11.35 16.98 16.26 19.79 18.47 19.47 21.07
EBIT Less CapEx to Interest Expense
14.29 17.14 20.86 21.52 14.00 23.23 20.55 26.81 24.57 27.10 28.95
NOPAT Less CapEx to Interest Expense
9.71 13.07 15.13 15.02 9.96 16.04 14.67 18.64 16.90 18.27 19.57
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
32.76% 30.80% 29.35% 28.68% 30.35% 30.95% 32.61% 31.92% 29.48% 27.97% 25.85%
Augmented Payout Ratio
47.10% 43.97% 40.37% 40.03% 54.20% 57.87% 59.38% 51.55% 39.87% 34.80% 31.91%

Financials Breakdown Chart

Key Financial Trends

Here's a concise, data-driven snapshot of Cboe Global Markets (NASDAQ:CBOE) using the last four years of quarterly statements. The focus is on notable trend signals in revenue, profitability, cash flow, and balance-sheet health.

  • Q4 2025 sales and margins: Operating revenue of 1,204,000,000 with total gross profit of 543,600,000 yields a gross margin of roughly 45%, indicating solid profitability at year-end.
  • Q4 2025 net income and EPS: Net income attributable to common shareholders of 312,200,000 with basic EPS of 2.99 and diluted EPS of 2.97, signaling strong quarterly profitability and favorable earnings per share.
  • Strong cash flow from operations: Net cash from continuing operating activities in Q4 2025 was 352,100,000, supporting a large positive net change in cash of 698,800,000 and indicating robust cash generation.
  • Healthy liquidity on the balance sheet: Cash & equivalents around 1.50B; total current assets about 3.74B vs. total current liabilities about 2.18B, suggesting solid near-term liquidity and financial flexibility.
  • Investing activities show constructive cash inflows: Net cash from continuing investing activities in Q4 2025 was 419,300,000, driven by asset sales and other investing activities, signaling some capital recycling opportunities.
  • Steady capital returns through dividends: The company maintains a regular dividend program, contributing to shareholder returns and perceived cash-on-cash yield stability.
  • Conservative debt profile: Long-term debt around 1.44B with no near-term liquidity crunches, reflecting a manageable leverage position and financial resilience.
  • Capex remains modest: Quarterly purchases of property, plant & equipment are modest (roughly in the teens of millions), indicating limited ongoing capital expenditure requirements.
  • Shares outstanding are relatively stable: Weighted average shares outstanding sit around the 104–105 million range, helping maintain EPS visibility over time.
  • Occasional one-time charges: Notable one-time items in 2025 include an impairment charge of about 4.5 million in Q3 2025 and restructuring charges in the same period (approximately 0.2 million), with a small restructuring impact also in Q4 2025; these mildly compress pretax income in those periods.
05/06/26 06:04 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Cboe Global Markets' Financials

When does Cboe Global Markets' financial year end?

According to the most recent income statement we have on file, Cboe Global Markets' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Cboe Global Markets' net income changed over the last 10 years?

Cboe Global Markets' net income appears to be on an upward trend, with a most recent value of $1.10 billion in 2025, rising from $205 million in 2015. The previous period was $764.90 million in 2024. See where experts think Cboe Global Markets is headed by visiting Cboe Global Markets' forecast page.

What is Cboe Global Markets' operating income?
Cboe Global Markets' total operating income in 2025 was $1.47 billion, based on the following breakdown:
  • Total Gross Profit: $1.93 billion
  • Total Operating Expenses: $461.20 million
How has Cboe Global Markets' revenue changed over the last 10 years?

Over the last 10 years, Cboe Global Markets' total revenue changed from $663.80 million in 2015 to $4.71 billion in 2025, a change of 610.2%.

How much debt does Cboe Global Markets have?

Cboe Global Markets' total liabilities were at $4.17 billion at the end of 2025, a 18.7% increase from 2024, and a 3,229.8% increase since 2015.

How much cash does Cboe Global Markets have?

In the past 10 years, Cboe Global Markets' cash and equivalents has ranged from $97.30 million in 2016 to $2.22 billion in 2025, and is currently $2.22 billion as of their latest financial filing in 2025.

How has Cboe Global Markets' book value per share changed over the last 10 years?

Over the last 10 years, Cboe Global Markets' book value per share changed from 3.15 in 2015 to 49.10 in 2025, a change of 1,459.4%.



Financial statements for BATS:CBOE last updated on 2/22/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners